Clinical Trial

Nebulized Nasal Steroids

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of the proposed project is to assess the efficacy, safety, and patient experience of budesonide administered via the NasoNeb system for medical management of CRS. The authors propose a randomized controlled trial of nebulized budesonide via the NasoNeb compared against budesonide lavage.
Trial Details
NCT Number NCT07270302
Lead Sponsor Washington University School of Medicine
Conditions Chronic Rhinosinusitis
Enrollment 50 participants
Start Date 2025-12
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-12-08